Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Hospira,
FDA Approves CYTARABINE — Hospira, Inc.

Hospira, Inc. received approval on June 4, 1990, for its intrathecal formulation of CYTARABINE (ANDA071868), a critical therapeutic addressing the sig...

TerSera
FDA Approves ZOLADEX — TerSera Therapeutics LLC

# FDA Drug Approval: TerSera Therapeutics' ZOLADEX TerSera Therapeutics LLC received FDA approval for ZOLADEX (goserelin acetate), a subcutaneous gon...

AbbVie
FDA Approves DEPAKOTE SPRINKLES — AbbVie Inc.

# FDA Approval Alert AbbVie Inc.'s DEPAKOTE SPRINKLES (divalproex sodium) oral formulation received FDA approval on September 12, 1989, establishing ...

PFIZER
FDA Approves Unknown Drug — PFIZER

# FDA Approves Pfizer Drug (NDA050639) Pfizer received FDA approval for a new drug application on August 30, 1989, expanding the company's pharmaceut...

ORGANON
FDA Approves Unknown Drug — ORGANON

Organon announced today that the FDA has cleared the marketing of NDA019796, a decision that allows the company to expand its product portfolio and ca...

Strides
FDA Approves ACETAMINOPHEN AND CODEINE PHOSPHATE — Strides Pharma Science Limited

Strides Pharma Science Limited announced the FDA approval of its ANDA089805 for oral Acetaminophen and Codeine Phosphate, positioning the company to c...

Strides
FDA Approves ACETAMINOPHEN AND CODEINE PHOSPHATE — Strides Pharma Science Limited

Strides Pharma Science Limited announced the FDA approval for Acetaminophen and Codeine Phosphate, a move anticipated to intensify competition in the ...

Strides
FDA Approves ACETAMINOPHEN AND CODEINE PHOSPHATE — Strides Pharma Science Limited

Strides Pharma Science Limited received approval on September 30, 1988, for the new ANDA for acetaminophen and codeine phosphate oral tablets, positio...

ALMAJECT
FDA Approves Unknown Drug — ALMAJECT

The FDA approved Unknown Drug from ALMAJECT under application ANDA062943 on 1988-09-29....

Hospira,
FDA Approves LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE — Hospira, Inc.

# FDA Approves Hospira's Lidocaine Hydrochloride and Epinephrine Combination Injection Hospira, Inc. received FDA approval for its lidocaine hydrochl...

Hospira,
FDA Approves LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE — Hospira, Inc.

# FDA Approves Hospira's Lidocaine Hydrochloride and Epinephrine for Epidural Use Hospira, Inc. has received FDA approval for its lidocaine hydrochlo...

Hospira,
FDA Approves LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE — Hospira, Inc.

Hospira, Inc. confirmed the FDA's approval of its ANDA for LidoCaine Hydrochloride and Epinephrine intended for epidural administration, a product lau...

B.
FDA Approves DEXTROSE AND SODIUM CHLORIDE — B. Braun Medical Inc.

B. Braun Medical Inc.'s long-standing legacy continues as the New Drug Application for Dextrose and Sodium Chloride remains fully active, reinforcing ...

Harrow
FDA Approves IOPIDINE 1% — Harrow Eye, LLC

# FDA Approves Harrow Eye's IOPIDINE (Apraclonidine Hydrochloride) for Ophthalmic Use Harrow Eye, LLC has received FDA approval for IOPIDINE 1% (apra...

Viatris
FDA Approves EPIPEN — Viatris Specialty LLC

Viatris Specialty LLC secured FDA approval for its epinephrine injectable product, expanding the availability of generic alternatives to the branded E...

Novartis
FDA Approves TEGRETOL — Novartis Pharmaceuticals Corporation

Novartis Pharmaceuticals Corporation announced today that the U.S. FDA has approved generic versions of Tegretol (carbamazepine), signaling potential ...

Baxter
FDA Approves IFOSFAMIDE — Baxter Healthcare Company

Baxter Healthcare Company has been granted regulatory confirmation for its intravenous formulation of ifosfamide, a product first approved in 1987, wh...

ALMAJECT
FDA Approves Unknown Drug — ALMAJECT

FDA approval for ALMAJECT’s ANDA signals the regulatory clearance to manufacture this generic substance, positioning the company to enter the market a...

ALMAJECT
FDA Approves Unknown Drug — ALMAJECT

Almaject announced the approval of its generic submission ANDA062801, marking the official introduction of a generic drug to the market in July 1987. ...

Sun
FDA Approves SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Sun Pharmaceutical Industries, Inc.

Sun Pharmaceutical Industries announced the FDA approval of its generic formulation of spironolactone and hydrochlorothiazide, which will broaden acce...